Literature DB >> 3695401

Pathology of experimental Babesia microti infection in the Syrian hamster.

J M Cullen1, J F Levine.   

Abstract

Pathologic changes produced after 4 weeks of infection by Babesia microti in Syrian hamsters are described and compared to babesiosis of humans. Following intraperitoneal inoculation, both intravascular and extravascular hemolysis developed. Up to 70% of red blood cells were parasitized. The principal morphologic abnormalities were an increase in extramedullary hematopoiesis and hyperplasia of the mononuclear phagocytic cells of the red pulp manifested grossly as splenomegaly, marked renal tubular hemosiderosis and hypertrophy of Kupffer cells. The disease was not fatal to any hamsters during the 4 week study. The clinical signs and lesions were less severe than fatal babesiosis of asplenic humans and similar to severe, but nonfatal disease in spleen intact humans. The hamster may serve as an animal model for the studying the pathophysiology of human babesiosis and for studying potential chemotherapeutic agents.

Entities:  

Mesh:

Year:  1987        PMID: 3695401

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  8 in total

1.  Comparison of Babesia microti Real-Time Polymerase Chain Reaction Assays for Confirmatory Diagnosis of Babesiosis.

Authors:  Samaly S Souza; Henry S Bishop; Patrick Sprinkle; Yvonne Qvarnstrom
Journal:  Am J Trop Med Hyg       Date:  2016-10-17       Impact factor: 2.345

2.  Establishment of a continuous in vitro culture of Babesia duncani in human erythrocytes reveals unusually high tolerance to recommended therapies.

Authors:  Amanah Abraham; Ioana Brasov; Jose Thekkiniath; Nicole Kilian; Lauren Lawres; Ruiyi Gao; Kai DeBus; Lan He; Xue Yu; Guan Zhu; Morven M Graham; Xinran Liu; Robert Molestina; Choukri Ben Mamoun
Journal:  J Biol Chem       Date:  2018-11-21       Impact factor: 5.157

3.  Differential effects of infection with a Babesia-like piroplasm, WA1, in inbred mice.

Authors:  M H Moro; C S David; J M Magera; P J Wettstein; S W Barthold; D H Persing
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

4.  Insights into the evolution and drug susceptibility of Babesia duncani from the sequence of its mitochondrial and apicoplast genomes.

Authors:  Azan Z Virji; Jose Thekkiniath; Wenxiu Ma; Lauren Lawres; James Knight; Andrea Swei; Karine Le Roch; Choukri Ben Mamoun
Journal:  Int J Parasitol       Date:  2018-08-31       Impact factor: 3.981

5.  Development of droplet digital PCR for the detection of Babesia microti and Babesia duncani.

Authors:  Melisa Wilson; Kathleen C Glaser; Debra Adams-Fish; Matthew Boley; Maria Mayda; Robert E Molestina
Journal:  Exp Parasitol       Date:  2014-12-08       Impact factor: 2.011

6.  Proteomic analysis reveals pathogen-derived biomarkers of acute babesiosis in erythrocytes, plasma, and urine of infected hamsters.

Authors:  Ruben Magni; Alessandra Luchini; Lance Liotta; Robert E Molestina
Journal:  Parasitol Res       Date:  2020-05-21       Impact factor: 2.383

Review 7.  Persistence of Babesia microti Infection in Humans.

Authors:  Evan M Bloch; Sanjai Kumar; Peter J Krause
Journal:  Pathogens       Date:  2019-07-17

8.  Evaluation of pathogen specific urinary peptides in tick-borne illnesses.

Authors:  Ruben Magni; Raghad Almofee; Sameen Yusuf; Claudius Mueller; Ngoc Vuong; Mahmood Almosuli; Minh Thu Hoang; Katherine Meade; Ish Sethi; Nuha Mohammed; Robyn Araujo; Teresa Kaza McDonald; Paul Marcelli; Virginia Espina; Brianna Kim; Anja Garritsen; Christine Green; Paul Russo; Weidong Zhou; Iosif Vaisman; Emanuel F Petricoin; Deborah Hoadley; Robert E Molestina; Hope McIntyre; Lance A Liotta; Alessandra Luchini
Journal:  Sci Rep       Date:  2020-11-09       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.